Search research articles
Contact Us
Filters
Showing results (241-250 of 342) with videos related to
Page
of 35
Sort By:
Journal of Cardiac Failure
|
November 18, 2021
Comparative Effectiveness of Dosing of Medical Therapy for Heart Failure: From the CHAMP-HF Registry
Stephen J Greene, Javed Butler, Anne S Hellkamp, et al.
Journal of the American College of Cardiology
|
April 26, 2008
Quality of care of and outcomes for African Americans hospitalized with heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) registry
Clyde W Yancy, William T Abraham, Nancy M Albert, et al.
Journal of Cardiac Failure
|
February 17, 2024
Patient and Provider Factors Associated With Initiating Sodium-Glucose Cotransporter-2 Inhibitors (SGTL2is) Following FDA Approval for Heart Failure With Preserved and Mildly Reduced Ejection Fraction
Trejeeve Martyn, Joshua Saef, Agam Bansal, et al.
American Heart Journal
|
February 16, 2010
Influence of dedicated heart failure clinics on delivery of recommended therapies in outpatient cardiology practices: findings from the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF)
Nancy M Albert, Gregg C Fonarow, Clyde W Yancy, et al.
Circulation. Heart Failure
|
August 31, 2012
National survey of hospital strategies to reduce heart failure readmissions: findings from the Get With the Guidelines-Heart Failure registry
Robb D Kociol, Eric D Peterson, Bradley G Hammill, et al.
American Heart Journal
|
January 26, 2021
Variation in use and dosing escalation of renin angiotensin system, mineralocorticoid receptor antagonist, angiotensin receptor neprilysin inhibitor and beta-blocker therapies in heart failure and reduced ejection fraction: Association of comorbidities
Nancy M Albert, Rachel J Tyson, C Larry Hill, et al.
Journal of the American Heart Association
|
June 20, 2022
Angiotensin Receptor Neprilysin Inhibition and Associated Outcomes by Race and Ethnicity in Patients With Heart Failure With Reduced Ejection Fraction: Data From CHAMP-HF
Brittany Chapman, Anne S Hellkamp, Laine E Thomas, et al.
American Heart Journal
|
July 24, 2007
Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: a report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)
Barry H Greenberg, William T Abraham, Nancy M Albert, et al.
The American Journal of Cardiology
|
June 12, 2010
Outpatient cardiology practices with advanced practice nurses and physician assistants provide similar delivery of recommended therapies (findings from IMPROVE HF)
Nancy M Albert, Gregg C Fonarow, Clyde W Yancy, et al.
Circulation. Heart Failure
|
November 2, 2013
Clinical effectiveness of cardiac resynchronization and implantable cardioverter-defibrillator therapy in men and women with heart failure: findings from IMPROVE HF
Jane E Wilcox, Gregg C Fonarow, Yan Zhang, et al.
Page
of 35
Search research articles
Search
Showing results (241-250 of 342) with videos related to
Sort By:
Page
of 35
Journal of Cardiac Failure
|
November 18, 2021
Comparative Effectiveness of Dosing of Medical Therapy for Heart Failure: From the CHAMP-HF Registry
Stephen J Greene, Javed Butler, Anne S Hellkamp, et al.
Journal of the American College of Cardiology
|
April 26, 2008
Quality of care of and outcomes for African Americans hospitalized with heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) registry
Clyde W Yancy, William T Abraham, Nancy M Albert, et al.
Journal of Cardiac Failure
|
February 17, 2024
Patient and Provider Factors Associated With Initiating Sodium-Glucose Cotransporter-2 Inhibitors (SGTL2is) Following FDA Approval for Heart Failure With Preserved and Mildly Reduced Ejection Fraction
Trejeeve Martyn, Joshua Saef, Agam Bansal, et al.
American Heart Journal
|
February 16, 2010
Influence of dedicated heart failure clinics on delivery of recommended therapies in outpatient cardiology practices: findings from the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF)
Nancy M Albert, Gregg C Fonarow, Clyde W Yancy, et al.
Circulation. Heart Failure
|
August 31, 2012
National survey of hospital strategies to reduce heart failure readmissions: findings from the Get With the Guidelines-Heart Failure registry
Robb D Kociol, Eric D Peterson, Bradley G Hammill, et al.
American Heart Journal
|
January 26, 2021
Variation in use and dosing escalation of renin angiotensin system, mineralocorticoid receptor antagonist, angiotensin receptor neprilysin inhibitor and beta-blocker therapies in heart failure and reduced ejection fraction: Association of comorbidities
Nancy M Albert, Rachel J Tyson, C Larry Hill, et al.
Journal of the American Heart Association
|
June 20, 2022
Angiotensin Receptor Neprilysin Inhibition and Associated Outcomes by Race and Ethnicity in Patients With Heart Failure With Reduced Ejection Fraction: Data From CHAMP-HF
Brittany Chapman, Anne S Hellkamp, Laine E Thomas, et al.
American Heart Journal
|
July 24, 2007
Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: a report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)
Barry H Greenberg, William T Abraham, Nancy M Albert, et al.
The American Journal of Cardiology
|
June 12, 2010
Outpatient cardiology practices with advanced practice nurses and physician assistants provide similar delivery of recommended therapies (findings from IMPROVE HF)
Nancy M Albert, Gregg C Fonarow, Clyde W Yancy, et al.
Circulation. Heart Failure
|
November 2, 2013
Clinical effectiveness of cardiac resynchronization and implantable cardioverter-defibrillator therapy in men and women with heart failure: findings from IMPROVE HF
Jane E Wilcox, Gregg C Fonarow, Yan Zhang, et al.
Page
of 35